Prostate cancer affects men all over the world and cutting edge research and clinical trials are happening right here in ...

Angel funds will conduct their first close by onboarding a minimum of five accredited investors, within 12 months from the date of SEBI communication for taking their private placement memorandum ...

Regulator Sebi on Wednesday proposed holding market infrastructure institutions and intermediaries accountable for any consequences arising from their use of artificial intelligence (AI ...

The Prostate Health Education Network launched a new online portal focused on precision medicine care for prostate cancer ...

The Securities and Exchange Board of India (SEBI) is looking to broaden the scope of Unpublished Price Sensitive Information (UPSI) to improve transparency in market disclosures. The new ...

Prostate cancer is the most common cancer in men in the United States aside from skin cancer. Dr. Jose Avitia, a medical ...

A recent study conducted by capital markets regulator Sebi revealed that listed companies paid royalties to related parties (RPs) exceeding 20 per cent of their net profits, which is one out of ...

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that ...

“We found this pattern surprising,” said Dr. Timothy Daskivich, director of Urologic Oncology Research for the Cedars-Sinai ...

To which Dr Hilary confirmed: "These are simple, not expensive, all basics." His advice comes backed by a 2016 study highlighting tomatoes' link to a lower risk of prostate cancer, also noting ...

After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...